Epicardial Mitral Repair Trial - ENRAPT-MR

NAUnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 18, 2017

Primary Completion Date

December 20, 2024

Study Completion Date

December 20, 2024

Conditions
Mitral Regurgitation
Interventions
DEVICE

Mitral Touch Implant

The study population for this study will be comprised of patients who are to undergo cardiac surgery with a sternotomy (e.g. CABG) and who present moderate to severe ischemic or functional MR. In order to be considered eligible for the study, each patient must meet the conditions listed in the inclusion and none of the exclusion criteria.

Trial Locations (1)

Unknown

RECRUITING

Vilnius University Hospital Santariskiu Klinikos, Vilnius

Sponsors
All Listed Sponsors
collaborator

Meditrial Europe Ltd.

INDUSTRY

collaborator

Medical Metrics Diagnostics, Inc

INDUSTRY

lead

Mitre Medical Corp.

INDUSTRY

NCT03864848 - Epicardial Mitral Repair Trial - ENRAPT-MR | Biotech Hunter | Biotech Hunter